Literature DB >> 20946323

The potential for clinical use of cannabinoids in treatment of cardiovascular diseases.

Ronen Durst1, Chaim Lotan.   

Abstract

Cannabinoids, the constituents of the marijuana plant and their analogs, have not only neurobehavioral but also cardiovascular effects. Great advances in the last couple of decades have led to better understanding of the physiological effects of the cannabinoids and of their role in various cardiovascular pathologies. The potential therapeutic use of cannabinoids in various cardiac diseases, such as ischemic injury, heart failure, and cardiac arrhythmias, has been studied in animal models. The purpose of this article is to review the physiological cardiovascular properties of cannabinoids and to summarize the knowledge related to their potential therapeutic use.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20946323     DOI: 10.1111/j.1755-5922.2010.00233.x

Source DB:  PubMed          Journal:  Cardiovasc Ther        ISSN: 1755-5914            Impact factor:   3.023


  9 in total

1.  Allostatic load and the cannabinoid system: implications for the treatment of physiological abnormalities in post-traumatic stress disorder (PTSD).

Authors:  James B Lohr; Hang Chang; Michelle Sexton; Barton W Palmer
Journal:  CNS Spectr       Date:  2019-07-15       Impact factor: 3.790

Review 2.  Exploration of Multiverse Activities of Endocannabinoids in Biological Systems.

Authors:  Tapan Behl; Rashita Makkar; Aayush Sehgal; Sukhbir Singh; Hafiz A Makeen; Mohammed Albratty; Hassan A Alhazmi; Abdulkarim M Meraya; Simona Bungau
Journal:  Int J Mol Sci       Date:  2022-05-20       Impact factor: 6.208

3.  Anandamide enhances expression of heat shock protein 72 to protect against ischemia-reperfusion injury in rat heart.

Authors:  Qian Li; Min Shi; Bo Li
Journal:  J Physiol Sci       Date:  2012-09-25       Impact factor: 2.781

Review 4.  Is the cardiovascular system a therapeutic target for cannabidiol?

Authors:  Christopher P Stanley; William H Hind; Saoirse E O'Sullivan
Journal:  Br J Clin Pharmacol       Date:  2013-02       Impact factor: 4.335

Review 5.  Huangqi injection (a traditional Chinese patent medicine) for chronic heart failure: a systematic review.

Authors:  Shufei Fu; Junhua Zhang; Francesca Menniti-Ippolito; Xiumei Gao; Francesca Galeotti; Marco Massari; Limin Hu; Boli Zhang; Rita Ferrelli; Alice Fauci; Fabio Firenzuoli; Hongcai Shang; Ranieri Guerra; Roberto Raschetti
Journal:  PLoS One       Date:  2011-05-06       Impact factor: 3.240

6.  Endocannabinoid system in cardiovascular disorders - new pharmacotherapeutic opportunities.

Authors:  Pedro Cunha; Ana M Romão; Filipa Mascarenhas-Melo; Helena M Teixeira; Flávio Reis
Journal:  J Pharm Bioallied Sci       Date:  2011-07

7.  Cannabinoid-Induced Autophagy and Heme Oxygenase-1 Determine the Fate of Adipose Tissue-Derived Mesenchymal Stem Cells under Stressful Conditions.

Authors:  Katharina Bublitz; Sabine Böckmann; Kirsten Peters; Burkhard Hinz
Journal:  Cells       Date:  2020-10-15       Impact factor: 6.600

Review 8.  Effect of Traditional Chinese Medicine on the Cardiovascular Diseases.

Authors:  Yang Jiang; Qi Zhao; Lin Li; Shumin Huang; Shuai Yi; Zhixi Hu
Journal:  Front Pharmacol       Date:  2022-03-21       Impact factor: 5.810

9.  Cannabidiol-mediated RISK PI3K/AKT and MAPK/ERK pathways decreasing reperfusion myocardial damage.

Authors:  Antonio Franco-Vadillo; Mireille Toledo-Blass; Zeltzin Rivera-Herrera; Gustavo Guevara-Balcazar; Oscar Orihuela-Rodriguez; Jose A Morales-Carmona; Alexandre Kormanovski-Kovzova; Pedro Lopez-Sanchez; Ivan Rubio-Gayosso; Maria Del Carmen Castillo-Hernandez
Journal:  Pharmacol Res Perspect       Date:  2021-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.